Change Country
Welcome to Norway
Please read the important information below before continuing to our website

Please read the important information below before continuing to our website.  

By clicking on your client type to enter the website, you are confirming that you have read and understood the important information that is contained below, and you accept the terms of the Privacy and Cookies policy.

THIS WEBSITE IS AIMED AT PROFESSIONAL CLIENTS IN NORWAY

This website is published by Lyxor International Asset Management (LIAM), a French asset management company approved by the AMF (17 place de la Bourse 75082 Paris Cedex 02) under the UCITS (2009/65/EC) and AIFM (2011/31/EU) directives.

The website is hosted by on Microsoft Azure servers.

This website is subject to French and Norwegian law.

 

A professional client is a client that is either a per se professional client or an elective professional client (Note article 4 (1) 12 of Mifid )

Marketing Restrictions and Implications

 

Lyxor UCITS compliant Exchange Traded Funds (Lyxor UCITS ETFs) referred to on this website are open ended mutual investment funds (i) established under the French law and approved by the Autorité des Marchés Financiers (the French Financial Markets Authority), or (ii) established under the Luxembourg law and approved by the Commission de Surveillance du Secteur Financier (the Luxembourg Financial Supervisory Committee). Most, , of the protections provided by the Danish regulatory system generally and for funds authorised in Denmark do not apply to these exchange traded funds (ETFs).

 

This website is exclusively intended for persons who are not "US persons", as such term is defined in Regulation S or the US Securities Act 1933, as amended, and who are not physically present in the US. This website does not constitute an offer or an invitation to purchase any securities in the United States or in any other jurisdiction in which such offer or invitation is not authorised or to any person to whom it is unlawful to make such offer or solicitation. Potential users of this website are requested to inform themselves about and to observe any such restrictions.

 

Index Replication Process

 

Lyxor UCITS ETFs follow both physical and synthetic index replication process.

 

However, most Lyxor UCITS ETFs follow synthetic replication process. This consists of entering into a derivative transaction (a ‘Performance Swap’, as defined below) with a counterparty that provides complete and effective exposure to its benchmark index. Lyxor has adopted this methodology in order to minimise tracking error, optimise transaction costs and reduce operational risks.

 

A Performance Swap is a contractual agreement which is negotiated over-the-counter (OTC) between two parties: the Lyxor UCITS ETF and its counterparty. From a risk perspective, each Performance Swap ranks equally with other senior unsecured obligations of the counterparty, such as common bonds (i.e., same rights to payments). In the Performance Swap, the counterparty of the Lyxor UCITS ETF commits to pay the Lyxor UCITS ETF a variable return based on a pre-determined benchmark index, instead of a fixed stream of income (as in bonds). At the same time, the counterparty will receive from the Lyxor UCITS ETF the performance and any related revenues generated by the basket's assets (excluding the value of the Performance Swap) held by the Lyxor UCITS ETF. Information provided on individual ETFs includes data on the basket relating to the ETF and the percentage value of the basket represented by each asset. The information is relevant to the closing values on the date given. 

 

Investment Risks

 

The Lyxor UCITS ETFs described on this website are not suitable for everyone. Investors' capital is at risk. Investors should not deal in this product unless they understand, having obtained independent professional advice where necessary, its nature, terms and conditions, and the extent of their exposure to risk. The value of the product can go down as well as up and can be subject to volatility due to factors such as price changes in the underlying instrument and interest rates. If a fund is quoted in a different currency to the index, currency risks exist.

 

Prior to any investment in any Lyxor UCITS ETF, you should make your own appraisal of the risks from a financial, legal and tax perspective, without relying exclusively on the information provided by us. We recommend that you consult your own independent professional advisors (including legal, tax, financial or accounting advisors, as appropriate).

 

Specific Risks

 

·         Capital at Risk. ETFs are tracking instruments: Their risk profile is similar to a direct investment in the Benchmark Index. Investors’ capital is fully at risk and investors may not get back the amount originally invested. Investments are not covered by the provisions of the Financial Services Compensation Scheme (“FSCS”), or any similar scheme.

·         Counterparty Risk. Investors may be exposed to risks resulting from the use of an OTC Swap with Societe Generale. Physical ETFs may have Counterparty Risk resulting from the use of a Securities Lending Programme.

·         Currency Risk. ETFs may be exposed to currency risk if the ETF or Benchmark Index holdings are denominated in a currency different to that of the Benchmark Index they are tracking. This means that exchange rate fluctuations could have a negative or positive effect on returns.

·         Replication Risk. ETFs are designed to replicate the performance of the Benchmark Index. Unexpected events relating to the constituents of the Benchmark Index may impact the Index provider’s ability to calculate the Benchmark Index, which may affect the ETF’s ability to replicate the Benchmark Index efficiently. This may create Tracking Error in the ETF.

·         Underlying Risk. The Benchmark Index of a Lyxor ETF may be complex and volatile. When investing in commodities, the Benchmark Index is calculated with reference to commodity futures contracts which can expose investors to risks related to the cost of carry and transportation. ETFs exposed to Emerging Markets carry a greater risk of potential loss than investment in Developed Markets as they are exposed to a wide range of unpredictable Emerging Market risks.

·         Liquidity Risk. On-exchange liquidity may be limited as a result of a suspension in the underlying market represented by the Benchmark Index tracked by the ETF; a failure in the systems of one of the relevant stock exchanges, Societe Generale or other Market Maker systems; or an abnormal trading situation or event. 

 

The securities can be neither offered in nor transferred to the United States.

 

Tax

 

Any statement in relation to tax, where made, is generic and non-exhaustive and is based on our understanding of the laws and practice in force as of the date of this document and is subject to any changes in law and practice and the interpretation and application thereof, which changes could be made with retroactive effect. Any such statement must not be construed as tax advice and must not be relied upon. The tax treatment of investments will, inter alia, depend on an individual’s circumstances. Investors must consult with an appropriate professional tax adviser to ascertain for themselves the taxation consequences of acquiring, holding and/or disposing of any investments mentioned on this website. 

Further information on the risk factors are available in the [Risk Warning – link to risk page] section of the website.

 

Any fund prospectus and supplements are available at www.lyxoretf.dk. Information given about the past performance of the funds is no guarantee of future performance. No investment decision should be taken without reading the fund prospectus and any fund supplement of the fund concerned.

 

Although the content of the website is based upon information that LIAM consider reliable or comes from sources that LIAM consider reliable, LIAM have not verified such information. Lyxor make no representation or warranty as to the accuracy, completeness or adequacy of any information.  Any reproduction, disclosure or dissemination of the materials available on the website is prohibited.

 

Cookies

This website uses cookies to make the website work or improve your user experience. Cookies are small text files that are saved on your computer or device, which are used for several purposes such as detecting preferences and improving site navigation. By continuing to use this website you consent for cookies to be used. For more details, including how to amend your preferences, please read our [Cookies Policy] link to privacy & cookie page.

By clicking on your client type to enter the website, you shall be deemed to have represented to us that you are not a U.S. person and that you are not located in the United States of America, its territories and possessions, and any State of the United States of America and that you are authorised to receive the information to and on this website.

August, 2015

 

 

 

I CONFIRM THAT I HAVE READ AND UNDERSTOOD THE IMPORTANT INFORMATION THAT IS CONTAINED ABOVE AND ACCEPT THE TERMS OF THE PRIVACY AND COOKIES POLICY.

By continuing to browse the site, you are agree on the use of cookies to track the number of visits.To know more about cookies policy:click here
04 Jul 2019

ESG Leaders and Laggards – 3 companies in focus

Well over 200 years ago, religious groups such as Quakers and Methodists were already pioneering early forms of Socially Responsible Investing (SRI), shunning businesses related to the likes of slave labour and harmful chemical production.1

In the 1960s, the civil rights movement took centre stage, with prominent figureheads such as Martin Luther King Jr. targeting companies opposing racial equality.2

By the 70s, much of the SRI efforts shifted towards corporate behaviour. Dow Chemical for instance came under heat for its role as the eventual sole provider of napalm in the Vietnam war.3 SRI even helped contribute to the end of Apartheid, thanks to international pressure to avoid investing in companies operating in South Africa.4

Moving on to the 80s and 90s, environmental concerns started gaining traction, from the health risks of fossil fuels to climate change.

ESG today is all about data

These days, popular forms of sustainable investing combine many of these issues through broad strategies with negative and/or exclusionary screens based on certain sectors or companies, as well as “best-in-class” screens focused on companies leading the way on ESG metrics.


Indeed, one of the fastest growing segments of ESG investing is the “best-in-class” approach, with a growth in global AuM of 125% between 2016 and 2018.5 And of the record-breaking €5.3bn of inflows into ESG ETFs in Europe year to date, almost three quarters went to broad “best-in-class” equity strategies.6

One of the main appeals of the “best-in-class” approach is the ability to keep a similar level of risk-adjusted return and sector exposure as non-ESG products. While there is a lingering myth that an ESG aligned portfolio sacrifices returns, it has largely been dispelled – one particular meta study reviewed over 2,000 papers and showed that ~90% of them found a non-negative link between ESG considerations and financial performance.7

Technology and culture have shifted. Today, we have swathes of high-quality data at our disposal thanks to increased disclosures from companies. As a result, sophisticated ETFs are available that can both align with your personal values, and still achieve a similar (if not better) risk/return profile to that of the broad market, with limited tracking error. Our ESG Leaders range is a good example.

MSCI World ESG Trend Leaders vs. parent index – ESG Ratings breakdown8

pie chart

ETFs and ESG share many qualities, daily transparency arguably chief amongst them. On that note, and to better illustrate what really goes on in your portfolio, we shed the light on three companies and their respective ESG profiles. The first two make the cut for our Lyxor MSCI World ESG Trend Leaders (DR) UCITS ETF, while the third one falls short.6

​​

Microsoft Corp. – an ESG “Leader”

MSCI ESG Rating: AAA9

Microsoft is an American multinational technology company specialised in the development, manufacturing and licensing of computer software, hardware and related services. Most of you are likely to have used one of their applications over the past week – if not in this very moment! Founded over 40 years ago, it boasts a market cap that recently crossed the $1tn mark.

With a top MSCI ESG Rating of AAA – held for three years running now – Microsoft is the corporate posterchild for what it means to be socially and environmentally responsible. In fact, the company scores so well that MSCI didn’t identify any areas of improvement relative to its peers.10 Unsurprisingly, Microsoft is the largest holding in our Lyxor MSCI World ESG Trend Leaders (DR) UCITS ETF.

One of Microsoft’s major strengths relates to Privacy & Data Security – probably one of the first things that comes to mind in the context of tech firms these days. Factors considered include whether the company’s privacy policies cover all relevant business lines, oversight on policies at board level, employee training on data privacy, and investments made to improve cybersecurity.

Microsoft is also recognised for its strong policies around Corruption & Instability. For a company that does a lot of government work, good business ethics is something you would naturally expect. Another strong point is its environmental considerations. Clean tech innovation lies at the heart of Microsoft, with investments in areas as varied as carbon neutrality, sustainable management of water, energy-efficient data centres, and waste minimisation.11

Fresenius Medical Care AG & Co. – “Average”, but improving

MSCI ESG Rating: BBB (up from BB)9

Fresenius Medical Care is a leading provider of products and services for people with chronic kidney failure. Headquartered in Germany, the company cares for more than 336,000 patients in a global network of more than 3,900 dialysis clinics.

Sustainable growth lies at the core of its strategy. Fresenius assumes a medical responsibility through its “patients first” principle, but also an economic responsibility based on “integrity, sound corporate governance and adherence to compliance principles”.12

Digging into MSCI’s ESG Rating, the company performs well in areas such as Carbon Emissions, Privacy & Data Security, Product Safety & Quality, and Corruption & Instability. Where it significantly underperforms versus its peers however is in Labour Management and Corporate Governance. This puts it just below its industry relative score, earning it an “Average” middle-ranking of BBB.

Worth noting, Fresenius has improved its ESG profile over time, having been upgraded from BB to BBB in its latest review. We believe that a positive change in ESG rating – “ESG trend” – can have a positive impact on share price. Our Lyxor MSCI World ESG Trend Leaders (DR) UCITS ETF takes both ESG rating and ESG trend into account, thereby rewarding the champions of change. So, while Fresenius doesn’t make the cut for the standard MSCI World ESG Leaders index, it does earn its place in our fund.

Mitsubishi Motors Co. – an ESG “Laggard”

MSCI ESG Rating: CCC9

Mitsubishi Motors is a Japanese multinational automotive manufacturer. Since October 2016, Mitsubishi has been one third owned by Nissan, and is part of the Renault-Nissan-Mitsubishi Alliance.

With an MSCI ESG Rating of CCC – the worst possible score – Mitsubishi does not qualify for any MSCI ESG Leaders indices. Perhaps not surprising, given its admission in 2016 that it had falsified fuel efficiency tests for the past quarter century, and the ensuing penalties, compensations and lasting reputational damage.

In early 2018, the company announced its recall of about 640,000 cars and SUVs worldwide because of a faulty accessory drive belt. The arrest in November 2018 of Mr. Carlos Ghosn – Chairman of the Renault-Nissan-Mitsubishi Alliance – over concerns around financial misconduct and governance further embroiled the company in controversy.

With regards to its MSCI ESG Rating, poor scores in key areas such as Product Safety & Quality and Corporate Governance meant Mitsubishi Motors was dragged down significantly, giving it a “Laggard” CCC rating.

Find out how you can “back the best” with our ESG Leaders ETFs

This article is for informative purposes only, and should not be taken as investment advice. Lyxor ETF does not in any way endorse or promote the companies mentioned in this article. The ESG Ratings mentioned in this article are determined by MSCI, not Lyxor ETF. Capital at risk. Please read our Risk Warning below.

1Source: Eurosif, European SRI Study 2018.
2Source: Investopedia, https://www.investopedia.com/terms/s/sri.asp
3Source: Bloomberg, https://www.bloomberg.com/news/features/2019-03-20/how-dow-chemical-got-woke
4Source: Journal of Business Ethics, https://www.jstor.org/stable/40785191?seq=1#page_scan_tab_contents
5Source: Global Sustainable Investment Alliance, 2018 Global Sustainable Investment Review.
6Source: Lyxor International Asset Management, Bloomberg, as at 30/06/2019.
7Source: Journal of Sustainable Finance & Investment, ESG and financial performance: aggregated evidence from more than 2000 empirical studies, Friede, Busch and Bassen, November 2015.
8Source: Lyxor International Asset Management, MSCI. Data as at 30/04/2019.
9Source: MSCI, as at June 2019.
10Source: MSCI, as at 31/03/2019.
11Source: Microsoft website, as at 02/07/2019.
12Source: Fresenius Medical Care website, as at 02/07/2019.

Risk Warning​

This document is for the exclusive use of investors acting on their own account and categorised either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets in Financial Instruments Directive 2014/65/EU. These products comply with the UCITS Directive (2009/65/EC). Société Générale and Lyxor International Asset Management (LIAM) recommend that investors read carefully the “investment risks” section of the product’s documentation (prospectus and KIID). The prospectus and KIID are available free of charge on www.lyxoretf.com, and upon request to client-services-etf@lyxor.com.

Except for the United-Kingdom, where this communication is issued in the UK by Lyxor Asset Management UK LLP, which is authorized and regulated by the Financial Conduct Authority in the UK under Registration Number 435658, this communication is issued by Lyxor International Asset Management (LIAM), a French management company authorized by the Autorité des marchés financiers and placed under the regulations of the UCITS (2014/91/EU) and AIFM (2011/61/EU) Directives. Société Générale is a French credit institution (bank) authorised by the Autorité de contrôle prudentiel et de résolution (the French Prudential Control Authority).

The products mentioned are the object of market-making contracts, the purpose of which is to ensure the liquidity of the products on the London Stock Exchange, assuming normal market conditions and normally functioning computer systems. Units of a specific UCITS ETF managed by an asset manager and purchased on the secondary market cannot usually be sold directly back to the asset manager itself. Investors must buy and sell units on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units and may receive less than the current net asset value when selling them. Updated composition of the product’s investment portfolio is available on www.lyxoretf.com. In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the product, and might also be mentioned on the websites of the stock exchanges where the product is listed.

Prior to investing in the product, investors should seek independent financial, tax, accounting and legal advice. It is each investor’s responsibility to ascertain that it is authorised to subscribe, or invest into this product. This document is of a commercial nature and not of a regulatory nature. This material is of a commercial nature and not a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor Asset Management (together with its affiliates, Lyxor AM) or any of their respective subsidiaries to purchase or sell the product referred to herein.

Research disclaimer

Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see appendix at the end of this report for the analyst(s) certification(s), important disclosures and disclaimers. Alternatively, visit our global research disclosure website www.lyxoretf.com/compliance.

Conflicts of interest 

This research contains the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to (i) ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees.

Connect with us on linkedin